Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2003
05/28/2003EP1314721A1 Novel propenohydroxamic acid derivatives
05/28/2003EP1314429A2 Use of an antiretroviral compound to manufacture a medicament for the treatment of sjogren's syndrome, systematic lupus erythematosis, scleroderma, or juvenile rheumatoid arthritis
05/28/2003EP1314426A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
05/28/2003EP1314039A2 Method for identifying peptides that can be specifically cleaved and the use of peptide sequences of this type
05/28/2003EP1313864A2 Anti-microbial agents
05/28/2003EP1313853A2 Modulation of fas and fasl expression
05/28/2003EP1313839A1 Immune potentiating compositions
05/28/2003EP1313820A2 Adhesive blends comprising hydrophilic and hydrophobic pressure sensitive adhesives
05/28/2003EP1313772A1 New cross-linked derivatives of hyaluronic acid
05/28/2003EP1313771A2 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections
05/28/2003EP1313769A2 Antibodies to human il-1 beta
05/28/2003EP1313751A1 New macrolides with antibacterial activity
05/28/2003EP1313749A2 Process for preparation of anhydrous azithromycin
05/28/2003EP1313738A1 Process for the preparation and purification of thiol-containing maytansinoids
05/28/2003EP1313731A1 Thiazolidine derivatives and its use as antifungal agent
05/28/2003EP1313711A2 Indazole derivatives as jnk inhibitors
05/28/2003EP1313710A1 Pyrazole derivatives and their use as protein kinase inhibitors
05/28/2003EP1313709A1 Pyrazolyl biphenyl carboxamides
05/28/2003EP1313705A1 Gem-substituted alpha v beta 3 integrin antagonists
05/28/2003EP1313699A1 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
05/28/2003EP1313689A1 Process for the preparation of phenylphenol compounds
05/28/2003EP1313512A1 Vascular endothelial growth factor 2
05/28/2003EP1313506A1 Immunologic method for the prevention of dental caries
05/28/2003EP1313505A1 Hla binding peptides and their uses
05/28/2003EP1313502A1 METHOD OF ADMINISTERING FimH PROTEIN AS A VACCINE FOR URINARY TRACT INFECTIONS
05/28/2003EP1313500A2 Combinations of dalfopristine/quinupristine with cefpirome
05/28/2003EP1313499A1 Method for treating the central nervous system by administration of igf structural analogs
05/28/2003EP1313497A1 Use of extracts of the cassia alata plant
05/28/2003EP1313487A1 Water-soluble amide derivatives of polyene macrolides and preparation and uses thereof
05/28/2003EP1313471A1 Benzylidene thiazolidinediones and their use as antimycotic agents
05/28/2003EP1313469A1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections
05/28/2003EP1313461A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
05/28/2003EP1313450A1 A method of treating a systemic disease
05/28/2003EP1313449A2 Amphotericin b structured emulsion
05/28/2003EP1313422A1 Non-hormonal vaginal contraceptive
05/28/2003EP1313377A2 Treatment of helicobacter with isothiocyanates
05/28/2003EP1244439A4 Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage
05/28/2003EP1232173B1 Fusidic acid derivatives
05/28/2003EP1231211B1 Thiazolidinedione derivatives as antidiabetic agents
05/28/2003EP1203002B1 Process for preparing a charcoal-gm1 complex
05/28/2003EP1200112B1 Chemokine binding protein of gammaherpesvirus 68 and methods of use therefor
05/28/2003EP1189903B1 Novel benzo[f]naphthyridine, preparation and compositions containing them
05/28/2003EP1175149B9 Disinfecting composition based on h2o2, acids and metal ions
05/28/2003EP1165115B1 Modulation of vascular permeability by mean of tie2 receptor activators
05/28/2003EP1150988B1 Phosphoramidate, and mono-, di-, and tri-phosphate esters of (1r, cis)-4-(6-amino-9h-purin-9-yl)-2-cyclopentene-1-methanol as antiviral agents
05/28/2003EP1070077B1 15-membered lactams ketolides with antibacterial activity
05/28/2003EP1039904B1 Synergistic antimicrobial compositions
05/28/2003EP0988048A4 Ligand/lytic peptide compositions and methods of use
05/28/2003EP0941100B1 Pharmaceutical compositions containing lamivudine and zidovudine
05/28/2003EP0939641B1 Topical products as prophylactic or curative agents for bacterial skin infections
05/28/2003EP0888352B1 Fused imidazole derivatives as multidrug resistance modulators
05/28/2003EP0788509B1 Therapeutic peptide derivatives
05/28/2003EP0788360B1 Boronic ester and acid compounds, synthesis and uses
05/28/2003EP0690715B1 Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses
05/28/2003EP0592546B1 Immunodeficiency virus recombinant poxvirus vaccine
05/28/2003EP0449958B9 Meningococcal class 1 outer-membrane protein vaccine
05/28/2003CN1420923A Infection of eukaryotic cells with viruses in vitro
05/28/2003CN1420891A Pharmaceutical compound
05/28/2003CN1420889A Pharmaceutically active isoindoline derivs.
05/28/2003CN1420888A Substd. pyrazoloÒÇö4,3-eÒÇòdiazepines, pharmaceu-tical compositions contg. them, use as medicinal products and processes for preparing them
05/28/2003CN1420884A 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders
05/28/2003CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha
05/28/2003CN1420879A Substd. pyridines and pyridazines with angiogenesis inhibiting activity
05/28/2003CN1420878A Compound with growth hormone releasing properties
05/28/2003CN1420872A Caspase inhibitors and use thereof
05/28/2003CN1420797A Method for improvement of islet signaling in diabetes mellitus and for its prevention
05/28/2003CN1420790A Transporters and drug delivery system by using same
05/28/2003CN1420786A Treatment of fungal infections with beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies
05/28/2003CN1420784A Vaccine for treatment of tubercolosis and other intracellular infections diseases and preparing process thereof
05/28/2003CN1420779A Nucleoside analogs with carboxamidine-modified bicyclic base
05/28/2003CN1420774A Sustained release beadlets conty. stavudine
05/28/2003CN1420763A Orally administered controlled delivery system for once daily administration of ciprofloxacin
05/28/2003CN1420723A Compositions and methods for L-nucleosides, and their analogs
05/28/2003CN1420120A Medicinal preparation contg. 1-N-ethyl vistamycin or its salt, and process for preparing same
05/28/2003CN1419935A Specific medicine for treatiug AIDs, cancer and hepatitis, and health product for recovery
05/28/2003CN1419916A Formulation and preparing process of medicinal particle for eliminating heat-fire and letting out toxin
05/28/2003CN1419913A Oral cavity disintegrating tablet of erythromycin ethylsuccinate for treating infection, and preparing method thereof
05/27/2003US6570002 Inhibitor of programmed cell death
05/27/2003US6570000 Nucleotide sequence coding monoclonal antibody for use in the treatment of viral diseases
05/27/2003US6569904 Via administration of toremifene for treatment or prevention of systemic/pulmonary hypertension, fibrosis, bronchial asthma, respiratory distress syndrome, myocardial infarction, thrombosis, congestive heart failure, and renal failure
05/27/2003US6569900 Fulvic acid and its use in the treatment of various conditions
05/27/2003US6569897 Alkenyldiarylmethane non-nucleoside HIV-1 reverse transcriptase inhibitors
05/27/2003US6569890 Cyclic AMP-specific phosphodiesterase inhibitors
05/27/2003US6569885 Cyclic AMP-specific phosphodiesterase inhibitors
05/27/2003US6569882 Viricides; enzyme inhibitors
05/27/2003US6569876 Method and structure for inhibiting activity of serine elastases
05/27/2003US6569871 Substituted imidazole compounds
05/27/2003US6569846 Photodynamic therapy and diagnosis and in vitro photodynamic killing of viruses and microorganisms
05/27/2003US6569842 Method of preparing and use of prodrugs of betulinic acid derivatives
05/27/2003US6569837 β-L-2′-deoxy pyrimidine nucleosides for the treatment of hepatitis B
05/27/2003US6569649 Compositions and methods for saccharide synthesis
05/27/2003US6569622 Nucleic acids encoding a protein conferring an inducible resistance to glycopeptide, particularly in gram-positive bacteria
05/27/2003US6569463 Encapsulation coat includes different combinations of pharmaceutical active ingredients, hydrophilic and lipophilic surfactants, and triglycerides
05/27/2003US6569457 Enteric coated pharmaceutical tablet and method of manufacturing
05/27/2003US6569443 Topical treatment or prevention of ocular infections
05/27/2003US6569424 A probiotic formulation of Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799); containing at least one volatile fraction (VF) of a plant extract
05/27/2003US6569422 Genetically engineered cell culture adapted infectious bursal diseases virus (IBDV) mutants
05/27/2003US6569420 Human interferon-ε: a type I interferon
05/27/2003US6569416 Compositions containing synthetic soil-extract materials and medicaments based thereon
05/27/2003CA2412624A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurogenerative diseases
1 ... 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 ... 1798